2012
DOI: 10.1007/978-1-4614-3381-1_16
|View full text |Cite
|
Sign up to set email alerts
|

Apoptosis of Breast Cancer Cells: Modulation of Genes for Glycoconjugate Biosynthesis and Targeted Drug Delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 114 publications
0
1
0
Order By: Relevance
“…This program cell death starts with changes in cell nuclear morphology (chromatin condensation and fragmentation), cell shrinking, plasma membrane blebbing, and apoptotic body formation. Cancer cells are known to express abnormally elevated levels of cytoprotective and antiapoptotic enzymes, which assist them to endure cellular stress and abrogate apoptosis, resulting in enhanced survival (Basu et al, 2012). Targeting cell apoptosis is, therefore, one of the promising approaches for cancer chemotherapeutic.…”
Section: Discussionmentioning
confidence: 99%
“…This program cell death starts with changes in cell nuclear morphology (chromatin condensation and fragmentation), cell shrinking, plasma membrane blebbing, and apoptotic body formation. Cancer cells are known to express abnormally elevated levels of cytoprotective and antiapoptotic enzymes, which assist them to endure cellular stress and abrogate apoptosis, resulting in enhanced survival (Basu et al, 2012). Targeting cell apoptosis is, therefore, one of the promising approaches for cancer chemotherapeutic.…”
Section: Discussionmentioning
confidence: 99%